BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19375307)

  • 1. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland.
    Montella A; Gavin A; Middleton R; Autier P; Boniol M
    Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
    McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
    Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001.
    Cayuela A; Rodríguez-Domínguez S; Lapetra-Peralta J; Conejo-Mir JS
    Br J Dermatol; 2005 May; 152(5):997-1000. PubMed ID: 15888159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993.
    Bulliard JL; Cox B
    Int J Epidemiol; 2000 Jun; 29(3):416-23. PubMed ID: 10869312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
    Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
    Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
    Jones ME; Shugg D; Dwyer T; Young B; Bonett A
    Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
    Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
    J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania.
    Stang A; Valiukeviciene S; Aleknaviciene B; Kurtinaitis J
    Eur J Cancer; 2006 Mar; 42(5):660-7. PubMed ID: 16510281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.
    Garbe C; Thiess S; Nürnberger F; Ehlers G; Albrecht G; Lindlar F; Bertz J
    Acta Derm Venereol; 1991; 71(6):506-11. PubMed ID: 1685833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of melanoma in Puerto Rico, 1987-2002.
    Valentín SM; Sánchez JL; Figueroa LD; Nazario CM
    P R Health Sci J; 2007 Dec; 26(4):343-8. PubMed ID: 18246962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
    Schneider JS; Moore DH; Mendelsohn ML
    J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in melanoma epidemiology suggest three different types of melanoma.
    Lipsker D; Engel F; Cribier B; Velten M; Hedelin G
    Br J Dermatol; 2007 Aug; 157(2):338-43. PubMed ID: 17596175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality trends in cutaneous malignant melanoma in Spain, 1967-1986.
    Pollán M; López-Abente G
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):545-50. PubMed ID: 8268771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonality of cutaneous melanoma diagnosis in Northern Ireland with a review.
    Chaillol I; Boniol M; Middleton R; Doré JF; Autier P; Gavin A
    Melanoma Res; 2011 Apr; 21(2):144-51. PubMed ID: 21317819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stage.
    Vranova J; Arenbergerova M; Arenberger P; Vrana A; Zivcak J; Kolarova H; Rosina J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):438-46. PubMed ID: 23128825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.